OmniAb, Inc.
OABI · XNASCIK 1846253fmd_1C2M9VJ83AA7R6992K81HAK2CVServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2007 to Sep 30, 2026, 23 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | 35 | 59 | 34 | 26 | 19 |
| Research and development | 39 | 48 | 57 | 55 | 48 |
| Total operating expenses | 70 | 86 | 104 | 101 | 88 |
| Operating income | (36) | (27) | (69) | (75) | (69) |
| Interest expense | 0 | 0 | – | – | – |
| Interest and investment income | 0 | 1 | 5 | 3 | 3 |
| Other non-operating income (expense) | 1 | 1 | 5 | 3 | 3 |
| Income before taxes | (34) | (26) | (64) | (71) | (66) |
| Income tax expense | (7) | (4) | (14) | (9) | (2) |
| Net income from continuing operations | (27) | (22) | (51) | (62) | (65) |
| Net income | (27) | (22) | (51) | (62) | (65) |